Cord blood is better than bone marrow for generating megakaryocytic progenitor cells
- PMID: 10029169
- DOI: 10.1016/s0301-472x(98)00050-2
Cord blood is better than bone marrow for generating megakaryocytic progenitor cells
Abstract
Thrombocytopenia remains an important problem for patients post high-dose chemotherapy and hematopoietic stem cell transplantation. The study of megakaryocytes, the direct precursors of platelets, has been hampered by their relatively low frequency in hematopoietic tissues. In an attempt to obtain a large number of functional megakaryocytic cells, we established a serum-free culture system to grow megakaryocytic progenitor cells derived from normal human bone marrow (BM) and cord blood (CB). Highly purified (purity >95%) CD34+ cells were obtained using magnetic cell sorting (MACS) followed by fluorescence activated cell sorting (FACS). The cells were cultured in a serum-free culture system for 3 weeks in the presence of a single dose of MGDF (50 ng/mL). On days 0, 5, 8, 12, 14, 18, and 21 of culture, the cellularity and morphology were examined. Megakaryocytic cells were monitored by detecting the expression of GPIIIa (CD61), GPIIb/IIIa (CD41) and GPIb (CD42b), and the distribution of megakaryocyte (MK) ploidy was analyzed by two-color flow cytometry. MGDF alone induced maximal nucleated cell expansion at day 14, resulting in a 38.20+/-10.47-fold increase in cell number for CB and a 5.08+/-1.30-fold increase in cell number for BM. On day 14 of the culture, the percentage of CD41-/CD14- cells derived from CB reached 73.54%+/-6.01% giving an absolute number of CD41+/CD14- cells of 27.25+/-2.23 x 10(4)/mL (27,250-fold increase), whilst the percentage of CD41+/CD14- cells derived from BM was only 29.21%+/-5.63% with an absolute number of 1.36+/-0.26 x 10(4)/mL (680-fold increase). Increased expression of GPIIIa occurred the earliest in culture, followed by GPIIb/IIIa, and then GPIb. The majority (81.6%-92.6%) of megakaryocytes (CD41+ cells) on day 14 of culture were 2N, although we did detect some 4N, 8N and greater ploidy cells. In conclusion, CD34+ cells stimulated by MGDF alone generated highly enriched MK progenitor cells at day 14 of serum-free culture. CB stem and progenitor cells have a greater proliferative response to MGDF alone than those derived from BM and may, therefore, prove to be a better source of cells for MK expansion.
Similar articles
-
Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.Exp Hematol. 1997 Oct;25(11):1125-39. Exp Hematol. 1997. PMID: 9328449
-
[Differences in megakaryocyte progenitor ex vivo expansion between CD34+ cells derived from human umbilical cord blood and bone marrow].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Dec;16(6):1398-402. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 19099652 Chinese.
-
Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood.Stem Cells Dev. 2005 Aug;14(4):415-24. doi: 10.1089/scd.2005.14.415. Stem Cells Dev. 2005. PMID: 16137231
-
Hierarchical structure of human megakaryocyte progenitor cells.Stem Cells. 1996;14 Suppl 1:75-81. doi: 10.1002/stem.5530140709. Stem Cells. 1996. PMID: 11012205 Review.
-
[Studies on ex vivo expansion of megakaryocytic progenitor and its application--review].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Aug;14(4):835-9. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006. PMID: 16928334 Review. Chinese.
Cited by
-
Differentiated Cells Derived from Hematopoietic Stem Cells and Their Applications in Translational Medicine.Adv Exp Med Biol. 2021;1347:29-43. doi: 10.1007/5584_2021_644. Adv Exp Med Biol. 2021. PMID: 34114129
-
Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.Haematologica. 2015 May;100(5):623-32. doi: 10.3324/haematol.2014.115634. Epub 2015 Feb 14. Haematologica. 2015. PMID: 25682608 Free PMC article.
-
Cell-based artificial platelet production: historical milestones, emerging trends, and future directions.Blood Res. 2025 May 27;60(1):32. doi: 10.1007/s44313-025-00071-9. Blood Res. 2025. PMID: 40423909 Free PMC article. Review.
-
Relieving DYRK1A repression of MKL1 confers an adult-like phenotype to human infantile megakaryocytes.J Clin Invest. 2022 Oct 3;132(19):e154839. doi: 10.1172/JCI154839. J Clin Invest. 2022. PMID: 35925681 Free PMC article.
-
Von Willebrand Disease: From In Vivo to In Vitro Disease Models.Hemasphere. 2019 Sep 27;3(5):e297. doi: 10.1097/HS9.0000000000000297. eCollection 2019 Oct. Hemasphere. 2019. PMID: 31942548 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous